Grifols Wins Early FDA OK For SCIg Xembify, Setting Stage For Margin Growth

 
• By Sten Stovall
Syringe
Self-Injectable Immunoglobulins treat primary and secondary immunodeficiencies • Source: Shutterstock

More from Business

More from Scrip